Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by Gram-positive and Gram-negative bacteria in human airway smooth muscle cells

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Issa, Razao ^a,c   Sorrentino, Rosalinda ^a   Sukkar, Maria B ^a   Sriskandan, Shiranee ^b   Chung, Kian Fan ^a   Mitchell, Jane A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NOVARTIS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CCL11 PROTEIN, HUMAN; DIACYLGLYCEROL; DRUG DERIVATIVE; EOTAXIN; FSL 1 LIPOPROTEIN, SYNTHETIC; FSL-1 LIPOPROTEIN, SYNTHETIC; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IL8 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; NOD1 PROTEIN, HUMAN; NOD2 PROTEIN, HUMAN; OLIGOPEPTIDE; PAM(3)CSK(4) PEPTIDE; PEPTIDE; POLYINOSINIC POLYCYTIDYLIC ACID; TACROLIMUS; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; BRONCHUS; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SMOOTH MUSCLE FIBER; STAPHYLOCOCCUS AUREUS; TIME;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; BRONCHI; CELLS, CULTURED; CHEMOKINE CCL11; DIGLYCERIDES; ESCHERICHIA COLI; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MYOCYTES, SMOOTH MUSCLE; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; OLIGOPEPTIDES; PEPTIDES; POLY I-C; STAPHYLOCOCCUS AUREUS; TACROLIMUS; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 43549103121     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-30     Document Type: Article

References (28)

1. Chung KF. Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation?. Eur Respir J 2000, 15:961-968. 10.1034/j.1399-3003.2000.15e26.x, 10853867.
2. Pang L, Knox AJ. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. FASEB J 2001, 15:261-269. 10.1096/fj.00-0103com, 11149914.
3. Knox AJ, Corbett L, Stocks J, Holland E, Zhu YM, Pang L. Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J 2001, 15:2480-2488. 10.1096/fj.01-0256com, 11689473.
4. Hirst SJ. Regulation of airway smooth muscle cell immunomodulatory function: role in asthma. Respiratory Physiology & Neurobiology 2003, 137:309-326. 10.1016/S1569-9048(03)00155-1, 14516734.
5. Pang L, Holland E, Knox AJ. Role of cyclo-oxygenase-2 induction in interleukin-1beta induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline. Br J Pharmacol 1998, 125:1320-1328. 1565701, 9863663, 10.1038/sj.bjp.0702193.
6. Fong CY, Pang L, Holland E, Knox AJ. TGF-beta 1 stimulates IL-8 release, COX-2 expression, and PGE2 release in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000, 279:L201-L207.
7. Oltmanns U, Chung KF, Walters M, John M, Mitchell JA. Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle. Respir Res 2005, 6:74. 1187925, 16029496, 10.1186/1465-9921-6-74.
8. Weinberger M. Respiratory infections and asthma: current treatment strategies. Drug Discov Today 2004, 9:831-837. 10.1016/S1359-6446(04)03239-8, 15381135.
9. Chinen J, Finkelman F, Shearer WT. Advances in basic and clinical immunology. J Allergy Clin Immunol 2006, 118:489-495. 10.1016/j.jaci.2006.05.021, 16890776.
10. Wagelie-Steffen AL, Kavanaugh AF, Wasserman SI. Biologic therapies for the treatment of asthma. Clin Chest Med 2006, 27:133-47. 10.1016/j.ccm.2005.10.001, 16543058.
11. Murphy TF. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 2006, 19:225-230. 10.1097/01.qco.0000224815.89363.15, 16645482.
12. Morris GE, Whyte MKB, Martin GF, Jose PJ, Dower SK, Sabroe I. Agonists of Toll-like Receptors 2 and 4 Activate Airway Smooth Muscle via Mononuclear Leukocytes. Am J Respir Crit Care Med 2005, 171:814-822. 10.1164/rccm.200403-406OC, 15657467.
13. Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol 2006, 118:641-648. 10.1016/j.jaci.2006.05.013, 16950283.
14. Morris GE, Parker LC, Ward JR, Jones EC, Whyte MK, Brightling CE, Bradding P, Dower SK, Sabroe I. Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J 2006, 20:2153-2155. 10.1096/fj.06-5910fje, 16935934.
15. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction. J Biol Chem 1999, 274:10689-10692. 10.1074/jbc.274.16.10689, 10196138.
16. Tanabe T, Chamaillard M, Ogura Y, Zhu L, Qiu S, Masumoto J, Ghosh P, Moran A, Predergast MM, Tromp G, Williams CJ, Inohara N, Núñez G. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004, 23:1587-1597. 391079, 15044951, 10.1038/sj.emboj.7600175.
17. Tada H, Aiba S, Shibata KI, Ohteki T, Takada H. Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells. Infect Immun 2005, 73:7967-7976. 1307098, 16299289, 10.1128/IAI.73.12.7967-7976.2005.
18. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA, Hwang DH. Saturated Fatty Acid Activates but Polyunsaturated Fatty Acid Inhibits Toll-like Receptor 2 Dimerized with Toll-like Receptor 6 or 1. J Biol Chem 2004, 279:16971-16979. 10.1074/jbc.M312990200, 14966134.
19. Inohara, Chamaillard, McDonald C, Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005, 74(355-83):355-383. 10.1146/annurev.biochem.74.082803.133347, 15952891.
20. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS. Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor for Escherichia and Salmonella Lipopolysaccharides. J Immunol 2000, 165:5780-5787.
21. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting Edge: Recognition of Gram-Positive Bacterial Cell Wall Components by the Innate Immune System Occurs Via Toll-Like Receptor 2. J Immunol 1999, 163:1-5.
22. Vogel SN, Fitzgerald KA, Fenton MJ. TLRs: Differential Adapter Utilization by Toll-Like Receptors Mediates TLR-Specific Patterns of Gene Expression. Mol Interv 2003, 3:466-477. 10.1124/mi.3.8.466, 14993454.
23. Paul-Clark MJ, McMaster SK, Belcher E, Sorrentino R, Anandarajah J, Fleet M, Sriskandan S, Mitchell JA. Differential effects of Gram-positive versus Gram-negative bacteria on NOSII and TNF[alpha] in macrophages: role of TLRs in synergy between the two. Br J Pharmacol 2006, 148:1067-1075. 1752017, 16783405, 10.1038/sj.bjp.0706815.
24. Oumouna M, Mapletoft JW, Karvonen BC, Babiuk LA, van D, Littel-van DH. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine. J Virol 2005, 79:2024-2032. 546558, 15681404, 10.1128/JVI.79.4.2024-2032.2005.
25. Niimi K, Asano K, Shiraishi Y, Nakajima T, Wakaki M, Kagyo J, Takihara T, Suzuki Y, Fukunaga K, Shiomi T, Oguma T, Sayama K, Yamaguchi K, Natori Y, Matsumoto M, Seya T, Yamaya M, Ishizaka A. TLR3-mediated synthesis and release of eotaxin-1/CCL11 from human bronchial smooth muscle cells stimulated with double-stranded RNA. J Immunol 2007, 178(1):489-495.
26. Hays SR, Ferrando RE, Carter R, Wong HH, Woodruff PG. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 2005, 60(3):226-228. 10.1136/thx.2004.028340, 15741440, 1747321.
27. Sutcliffe AM, Knox AJ. Muscling into cystic fibrosis airways. Thorax 2005, 60(3):181-182. 10.1136/thx.2004.035840, 15741431, 1747341.
28. Vanaudenaerde BM, Wuyts WA, Geudens N, Dupont LJ, Schoofs K, Smeets S, Van Raemdonck DE, Verleden GM. Macrolides inhibit IL-17 induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007, 7(1):76-82. 10.1111/j.1600-6143.2006.01586.x, 17061983.